DiaGenic ASA announced that Paul de Potocki will assume the position of President and Chief Executive Officer of the company. Paul de Potocki will succeed Henrik Lund, who has led the development of DiaGenic on an interim basis since April 2012. Paul de Potocki will assume the position as Chief Executive Officer medio September the year 2012. Paul de Potocki brings more than 20 years of international business management experience to the company. He joins DiaGenic after serving as Chief Executive Officer of Aerocrine AB. Prior to joining Aerocrine, he has served as Senior Vice President, Commercial and Strategic Development at Biovitrum AB.